Meet Harith Rajagopalan, Fractyl Labs Founder

Harith Rajagopalan's Work History

Harith Rajagopalan has a diverse career as an academic cardiologist and physician-scientist, with extensive research and leadership in biotech. He co-founded Fractyl in 2010, where he has served as CEO, focusing on novel therapeutic platforms for metabolic health.

• 2011-07-01 — Co-Founder and CEO, Fractyl Health
• 2011-07-01 - 2024-06-01 — Co-Founder and CEO, Fractyl Laboratories
• 2018-01-01 - 2024-06-01 — Member, Editorial Advisory Board, TEDMED
• 2009-02-01 - 2011-06-01 — Entrepreneur- and Technologist-in Residence, General Catalyst Partners
• 2007-07-01 - 2011-06-01 — Cardiovascular Fellow, Brigham and Women’s Hospital
• 1998-01-01 - 2005-01-01 — MD/PhD Candidate, Johns Hopkins School of Medicine

Harith Rajagopalan's Education

Harith earned his B.S. in chemistry from Stanford University and completed his MD and Ph.D. in Cancer Genetics at Johns Hopkins School of Medicine. He also trained in internal medicine and cardiology at Brigham and Women’s Hospital and Harvard Stem Cell Institute.

• Stanford University — B.S. in Chemistry
• Johns Hopkins School of Medicine — MD, PhD in Cancer Genetics

About Fractyl Labs

Fractyl Health develops innovative therapies targeting the root causes of obesity and type 2 diabetes, including the Revita procedure and gene therapy platforms, aiming to prevent and reverse metabolic diseases.

Fractyl Labs Funding

Founded in 2010, Fractyl has raised significant funding, went public via NASDAQ in February 2024, and focuses on therapies for metabolic diseases.

How to Reach Harith Rajagopalan?

You can reach Harith Rajagopalan at *******@fractyl.com or by calling +1 **********. To get Harith Rajagopalan's contact information and other startup founders like this, sign up for a free account at Anybody.com.